# Francesco Massari

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francesco-massari/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,238 |
| Field | Renal cell carcinoma treatment |
| h-index | 67 |
| i10-index | 354 |
| Last Known Institution | Altera (United States) |
| OpenAlex ID | https://openalex.org/A5063795761 |
| ORCID iD | https://orcid.org/0000-0001-6476-6871 |
| Works | 853 |

## Researcher papers

- [Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony](https://scholariq.org/papers/cardiac-resynchronization-therapy-tailored-by-echocardiographic-evaluation-of/)
- [Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-in-patients-with/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Altera (United States)](https://scholariq.org/institutions/altera-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.